Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. Article uri icon

Overview

publication date

  • May 1, 2014

Research

keywords

  • Antineoplastic Agents
  • Immunoconjugates
  • Pancreatitis

Identity

PubMed Central ID

  • PMC4007615

Scopus Document Identifier

  • 84903139938

Digital Object Identifier (DOI)

  • 10.1182/blood-2014-03-561878

PubMed ID

  • 24786458

Additional Document Info

volume

  • 123

issue

  • 18